MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Autosomal dominant Parkinson’s disease caused by SNCA p.E46K variant in family with Russian ancestry: A case report

K. Senkevich, I. Miliukhina, A. Zhuravlev, M. Shumilova, M. Beletskaia, A. Tyurin, M. Grunina, A. Rybakov, J. Ahmad, F. Asayesh, A. Timofeeva, Z. Gan-Or, A. Emelyanov, S. Pchelina (Montreal, Canada)

Meeting: 2023 International Congress

Abstract Number: 1132

Keywords: Alpha-synuclein, Familial neurodegenerative diseases, Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: To report a family with autosomal dominant Parkinson’s disease (PD) with SNCA p.E46K variant.

Background: Alpha–synuclein, encoded by SNCA, is a part of Lewy bodies [1,2]. Accumulation of Lewy bodies in substantia nigra is a prominent feature of PD [3]. Several point mutations associated with PD have been previously described, including (p.A30P, p.A30G, p.E46K, p.G51D, p.A53T, p.A53E and p.A53V) [4,5]. However, SNCA p.E46K was reported only in two families (Basque and Bolivian with Spanish ancestry) with PD [6,7].

Method: In the current study, we performed targeted sequencing of SNCA using molecular inversion probes in 497 PD patients and 401 controls from Pavlov First State Medical university and Institute of Human Brain. Our cohort included 34 patients with early onset of PD (<50 years). We performed an analysis of known pathogenic variants within SNCA. We then confirmed the detected pathogenic variant using sanger sequencing. Total alpha-synuclein level in peripheral blood mononuclear cells (PBMCs) was estimated by western blot.

Results: We detected a singular pathogenic heterozygous SNCA p.E46K variant in a 45-year-old PD patient with early PD onset at 20 years [III-1,figure 1]. The patient had a slow progression of motor symptoms with a good response to Levo-dopa and a variety of non-motor symptoms, including depression, delusions, cognitive deficiency, rapid-eye-movement sleep behavior disorder and a decreased sense. The patient developed early motor fluctuations and dyskinesia and received bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) after 11 years of disease progression. There was a clear autosomal dominant inheritance [figure 1]. The mother of the patient developed PD symptoms when she was 37 years old, and she died at the age of 39. The cause of death is not known for certain. The patient’s grandmother also had early symptoms of PD (precise age-at-onset is not known) and died at the age of 63. The father of the patient was the wild type to SNCA p.E46K. Total alpha-synuclein level was markedly elevated in PD patient with SNCA p.E46K compared to sporadic PD and controls (p<0.01).

Conclusion: Here, we present a family of Russian ancestry with autosomal dominant PD and early onset due to SNCA p.E46K mutation. To our best knowledge, it is the third family reported worldwide and the first family of non-Spanish ancestry.

Figure 1

References: 1. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388(6645):839-840.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997;276(5321):2045-2047.
3. Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders. Molecular Neurobiology 2013;47(2):495-508.
4. Stefanis L. α-Synuclein in Parkinson’s disease. Cold Spring Harb Perspect Med 2012;2(2):a009399.
5. Brás J, Gibbons E, Guerreiro R. Genetics of synucleins in neurodegenerative diseases. Acta Neuropathologica 2021;141(4):471-490.
6. Zarranz JJ, Alegre J, Gómez‐Esteban JC, et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 2004;55(2):164-173.
7. Pimentel MM, Rodrigues FC, Leite MAA, et al. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p. E46K mutation. Parkinsonism & Related Disorders 2015;21(6):586-589.

To cite this abstract in AMA style:

K. Senkevich, I. Miliukhina, A. Zhuravlev, M. Shumilova, M. Beletskaia, A. Tyurin, M. Grunina, A. Rybakov, J. Ahmad, F. Asayesh, A. Timofeeva, Z. Gan-Or, A. Emelyanov, S. Pchelina. Autosomal dominant Parkinson’s disease caused by SNCA p.E46K variant in family with Russian ancestry: A case report [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/autosomal-dominant-parkinsons-disease-caused-by-snca-p-e46k-variant-in-family-with-russian-ancestry-a-case-report/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/autosomal-dominant-parkinsons-disease-caused-by-snca-p-e46k-variant-in-family-with-russian-ancestry-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley